We are live on ! Find out more
BBP icon

Virtus Biotech ETF

14 hedge funds and large institutions have $10.7M invested in Virtus Biotech ETF in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

8% more funds holding

Funds holding: 1314 (+1)

3% more capital invested

Capital invested by funds: $10.4M → $10.7M (+$308K)

0.96% more ownership

Funds ownership: 40.01%40.97% (+0.96%)

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
5
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

BBP Hedge Fund Activity: Q3 2020 in Review

14 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q3 2020, worth a combined $10.7M — up 3% from $10.4M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BBP positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Smart Money Group, adding an estimated $293K. The largest seller was Private Advisor Group, exiting entirely with an estimated $104K sold.

  • 14 institutional investors held Virtus Biotech ETF (BBP) as of Q3 2020, up from 13 in Q2 2020.
  • Funds reported $10.7M of Virtus Biotech ETF stock for Q3 2020, up 3% quarter-over-quarter.
  • 3 funds opened new Virtus Biotech ETF positions in Q3 2020 and 2 closed out, a net change of +1 holder.
  • The largest Virtus Biotech ETF buyer in Q3 2020 was Smart Money Group, an estimated $293K added.
  • The largest Virtus Biotech ETF seller in Q3 2020 was Private Advisor Group, an estimated $104K sold.

Based on aggregated 13F filings for Q3 2020.